144 related articles for article (PubMed ID: 38186621)
1. Curcumol metabolized by rat liver S9 fraction and orally administered in mouse suppressed the proliferation of colon cancer in vitro and in vivo.
Zhou Y; Moon JH; Kim JT; Qiu S; Lee SB; Park HJ; Son MJ; Lee GY; Kwon JW; Park SH; Auh JH; Lee HJ
Food Sci Biotechnol; 2024 Jan; 33(1):171-180. PubMed ID: 38186621
[TBL] [Abstract][Full Text] [Related]
2. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
[TBL] [Abstract][Full Text] [Related]
3. Curcumol increases the sensitivity of colon cancer to 5-FU by regulating Wnt/β-catenin signaling.
Gao J; Hou D; Hu P; Mao G
Transl Cancer Res; 2021 May; 10(5):2437-2450. PubMed ID: 35116559
[TBL] [Abstract][Full Text] [Related]
4. The molecular mechanism of curcumol on inducing cell growth arrest and apoptosis in Jurkat cells, a model of CD4⁺ T cells.
Wang H; Wang Y; Jiang X; Wang Z; Zhong B; Fang Y
Int Immunopharmacol; 2014 Aug; 21(2):375-82. PubMed ID: 24877754
[TBL] [Abstract][Full Text] [Related]
5.
Park J; Moon SK; Lee C
Front Pharmacol; 2023; 14():1146966. PubMed ID: 37007044
[No Abstract] [Full Text] [Related]
6. Curcumol induces HSC-T6 cell death through suppression of Bcl-2: involvement of PI3K and NF-κB pathways.
Chen G; Wang Y; Li M; Xu T; Wang X; Hong B; Niu Y
Eur J Pharm Sci; 2014 Dec; 65():21-8. PubMed ID: 25220584
[TBL] [Abstract][Full Text] [Related]
7. Curcumol triggers apoptosis of p53 mutant triple-negative human breast cancer MDA-MB 231 cells via activation of p73 and PUMA.
Huang L; Li A; Liao G; Yang F; Yang J; Chen X; Jiang X
Oncol Lett; 2017 Jul; 14(1):1080-1088. PubMed ID: 28693277
[TBL] [Abstract][Full Text] [Related]
8. Histone methylatic modification mediates the tumor-suppressive activity of curcumol in hepatocellular carcinoma via an Hotair/EZH2 regulatory axis.
Tian NN; Zheng YB; Li ZP; Zhang FW; Zhang JF
J Ethnopharmacol; 2021 Nov; 280():114413. PubMed ID: 34265379
[TBL] [Abstract][Full Text] [Related]
9. Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathway.
Yu YH; Zhang HJ; Yang F; Xu L; Liu H
J Ethnopharmacol; 2023 Jun; 310():116311. PubMed ID: 36894110
[TBL] [Abstract][Full Text] [Related]
10. Curcumol Inhibits Growth and Induces Apoptosis of Colorectal Cancer LoVo Cell Line via IGF-1R and p38 MAPK Pathway.
Wang J; Huang F; Bai Z; Chi B; Wu J; Chen X
Int J Mol Sci; 2015 Aug; 16(8):19851-67. PubMed ID: 26307972
[TBL] [Abstract][Full Text] [Related]
11. Curcumol inhibits breast cancer growth
Wei ZL; Juan W; Tong D; Juan LX; Sa LY; Jie HFM; Xiao G; Xiang LG; Jie HM; Xu C
Food Funct; 2023 Jan; 14(2):874-885. PubMed ID: 36537297
[No Abstract] [Full Text] [Related]
12. Curcumol induces cell cycle arrest and apoptosis by inhibiting IGF-1R/PI3K/Akt signaling pathway in human nasopharyngeal carcinoma CNE-2 cells.
Li X; Liu H; Wang J; Qin J; Bai Z; Chi B; Yan W; Chen X
Phytother Res; 2018 Nov; 32(11):2214-2225. PubMed ID: 30069933
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, tissue distribution, and plasma protein binding rate of curcumol in rats using liquid chromatography tandem mass spectrometry.
Yang Z; Sun Q; Wang S; Tang B; Yuan C; Wu Y; Dai J; Yang C; Wang L; Zhou Q; Wang J; Weng Q
Front Pharmacol; 2022; 13():1036732. PubMed ID: 36532730
[No Abstract] [Full Text] [Related]
14. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
[TBL] [Abstract][Full Text] [Related]
15. Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer.
Cai F; Chen M; Zha D; Zhang P; Zhang X; Cao N; Wang J; He Y; Fan X; Zhang W; Fu Z; Lai Y; Hua ZC; Zhuang H
Oncotarget; 2017 Dec; 8(70):115526-115545. PubMed ID: 29383179
[TBL] [Abstract][Full Text] [Related]
16. Curcumol enhances the anti-tumor effects of metformin via suppressing epithelial-mesenchymal transition in triple-negative breast cancer.
Wang G; Dong Y; Liu H
Ann Transl Med; 2020 Aug; 8(15):946. PubMed ID: 32953746
[TBL] [Abstract][Full Text] [Related]
17. Curcumol attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via TGF-β1.
Yan D; Deng S; Gan W; Li S; Li Y
Mol Med Rep; 2018 Jun; 17(6):7513-7520. PubMed ID: 29620189
[TBL] [Abstract][Full Text] [Related]
18. A Study on Curcumol Influencing Proliferation and Apoptosis of Hepatocellular Carcinoma Cells through DJ-1/PTEN/PI3K/AKT Pathway.
Zhang R; Zhong L; Sun K; Liu J; Wang Q; Mao D; Fang G; Long F
Biomed Res Int; 2022; 2022():9912776. PubMed ID: 35647179
[TBL] [Abstract][Full Text] [Related]
19. Identification of the Metabolites of Both Formononetin in Rat Hepatic S9 and Ononin in Rat Urine Samples and Preliminary Network Pharmacology Evaluation of Their Main Metabolites.
Yang YZ; Wang T; Chen QL; Chen HB; He QS; Zhang YZ
Molecules; 2023 Nov; 28(21):. PubMed ID: 37959870
[No Abstract] [Full Text] [Related]
20. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis.
Zeng C; Fan D; Xu Y; Li X; Yuan J; Yang Q; Zhou X; Lu J; Zhang C; Han J; Gu J; Gao Y; Sun L; Wang S
Biochem Pharmacol; 2020 Apr; 174():113795. PubMed ID: 31926937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
